- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 279/06 - Thiazines-1, 3Thiazines-1, 3 hydrogénées non condensés avec d'autres cycles
Détention brevets de la classe C07D 279/06
Brevets de cette classe: 51
Historique des publications depuis 10 ans
|
3
|
2
|
3
|
2
|
5
|
4
|
4
|
4
|
0
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Shionogi & Co., Ltd. | 844 |
10 |
| Pliant Therapeutics, Inc. | 67 |
3 |
| The Regents of the University of California | 20108 |
2 |
| Bayer Cropscience AG | 2014 |
2 |
| Vertex Pharmaceuticals Incorporated | 1626 |
2 |
| East China University of Science and Technology | 520 |
2 |
| The Feinstein Institute for Medical Research | 253 |
2 |
| The Penn State Research Foundation | 1544 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3186 |
2 |
| Shanghai ChemPartner Co., Ltd. | 3 |
2 |
| Bristol-myers Squibb Company | 4849 |
1 |
| Glaxosmithkline LLC | 535 |
1 |
| Centre National de La Recherche Scientifique | 10564 |
1 |
| Sumitomo Chemical Company, Limited | 9079 |
1 |
| President and Fellows of Harvard College | 6002 |
1 |
| Arkema France | 4168 |
1 |
| Eli Lilly and Company | 3902 |
1 |
| Fudan University | 697 |
1 |
| Gowan Company, L.L.C. | 137 |
1 |
| Institute of Medicinal Molecular Design, Inc. | 7 |
1 |
| Autres propriétaires | 12 |